Adult · ACLS
Bradycardia with a pulse
A slow heart rate matters when it causes poor perfusion. The first decision is whether this bradycardia, in this patient, is producing hypotension, confusion, shock, ischemic chest pain or heart failure.
Guidelines: AHA 2020 with the 2023 update and confirmed 2025 changes; PALS 2020 with the 2025 pediatric updates
Reflects the AHA 2020 adult algorithms with the 2023 focused update, updated for the 2025 AHA Guidelines for CPR and ECC where the change could be confirmed; acute coronary syndromes follow the 2025 ACC/AHA guideline and stroke the 2026 AHA/ASA guideline. Pediatric content follows the AHA 2020 PALS algorithms with the 2025 AHA/AAP pediatric updates where confirmed.
Walk through it
One step at a time. Each step says what to do and why; at a decision, choose the branch that fits your patient. The map shows where you are.
The interactive walk needs JavaScript. Every step is listed below.
Every step at once
Start
Is the rate appropriate for the patient?
- A bradyarrhythmia usually has a rate below 50/min.
- A fit athlete at 45/min is not a patient.
Why: The algorithm treats symptoms caused by a slow rate, not the number on the monitor.
Rhythm: Sinus bradycardia
Do
Identify and treat the underlying cause
- Airway and breathing; oxygen if hypoxemic.
- Monitor, blood pressure, SpO₂, IV access.
- 12-lead ECG if it does not delay treatment.
- Think: hypoxia, inferior MI, drugs (beta-blockers, calcium-channel blockers, digoxin), hyperkalemia, hypothermia, raised ICP.
Why: Hypoxia is the most common reversible cause of bradycardia, especially in children and in respiratory failure. Oxygen fixes it faster than any drug.
Decide
Is the slow rate causing hypotension, altered mental status, shock, ischemic chest pain or acute heart failure?
- Look for signs of poor perfusion.
Why: These are signs that cardiac output is failing. Output is rate times stroke volume; when stroke volume cannot rise any further, a slow rate means a falling output.
Then
Monitor and observe
- Find the cause; record a 12-lead ECG.
- Expert consultation for Mobitz II or third-degree block, even if stable: they can fail suddenly.
Why: A stable patient has time. A high-grade block does not stay stable forever, so pads on and a plan ready.
Do
Atropine 1 mg IV
- Repeat every 3–5 minutes, to a maximum of 3 mg.
- In Mobitz II or third-degree block with a wide escape, prepare to pace at the same time: do not wait for atropine to fail.
Why: Atropine blocks the vagus at the sinus and AV nodes. If the block is below the AV node (wide escape, Mobitz II) the vagus is not the problem and atropine has nothing to act on.
Drugs: Atropine
Rhythm: Third-degree AV block, ventricular escape
Then: Did atropine work?
Decide
Did atropine work?
Why: A response means the problem was vagal or nodal. No response points to infranodal disease or a cause atropine cannot reach.
Decide
Second line: choose one or more
Why: Pacing bypasses the conduction system entirely; the infusions push the escape pacemaker and contractility harder. Which to start first depends on what is fastest at the bedside.
Do
Transcutaneous pacing
- Pads anterior–posterior (or anterior–lateral).
- Set a rate (commonly 60–80/min), raise the output until every spike captures, then set it slightly above that threshold.
- Confirm mechanical capture with a femoral pulse.
- Analgesia and sedation as tolerated.
Why: An external current depolarizes the ventricles directly. Electrical capture on the monitor is not enough: only a pulse proves the heart is contracting with each beat.
Rhythm: Ventricular paced rhythm
Do
Dopamine infusion 5–20 mcg/kg/min
- Titrate to response; taper slowly.
Why: Beta-1 effects raise rate and contractility; alpha effects at higher doses support pressure.
Drugs: Dopamine infusion
Do
Epinephrine infusion 2–10 mcg/min
- Titrate to response.
Why: A strong beta-1 stimulus for rate and contractility, with alpha support for pressure.
Drugs: Epinephrine infusion
Then
Consider expert consultation and transvenous pacing
- Transcutaneous pacing is a bridge: arrange a transvenous wire.
- Keep treating the cause (for example, potassium, toxins, ischemia).
Why: External pacing is painful and capture can be lost; a transvenous wire is the reliable bridge to a permanent solution.
The rhythms
Sinus bradycardia
Often physiological; treat the patient, not the number.
Mobitz II
Can progress suddenly to complete block.
Entry: Second-degree AV block, Mobitz II
Third-degree AV block
A wide escape rhythm is unreliable: prepare to pace.
Entry: Third-degree AV block, ventricular escape
Sick sinus syndrome
Pauses after bursts of tachycardia.
Entry: Sick sinus syndrome (tachy-brady)
At a glance
The whole algorithm on one page. Read from the top; a decision splits the path.
Start
Assess
- Is the heart rate appropriate for the clinical condition? A bradyarrhythmia usually has a rate below 50/min.
Do
Identify and treat the underlying cause
- Maintain the airway; assist breathing as needed.
- Oxygen if hypoxemic.
- Cardiac monitor, blood pressure and oximetry; IV access.
- 12-lead ECG if available; do not delay therapy.
- Consider hypoxic and toxicologic causes.
Decide
Is the bradyarrhythmia causing any of these?
- Hypotension
- Acutely altered mental status
- Signs of shock
- Ischemic chest discomfort
- Acute heart failure
No
Then
Monitor and observe
- Look for the cause; record a 12-lead ECG; seek expert advice for high-grade AV block.
Yes
Do
Atropine
- Atropine may not work in high-grade (Mobitz II or third-degree) block with a wide escape rhythm or after heart transplant: do not let it delay pacing.
Decide
Atropine ineffective?
- Then one or more of:
Do
Transcutaneous pacing
- Confirm electrical and mechanical capture (see Electrical therapy).
- Give analgesia and sedation as tolerated.
Do
or a chronotropic infusion
- Dopamine or epinephrine infusion.
Then
Consider
- Expert consultation.
- Transvenous pacing.
Key points
Reading the rhythm
- Name the rhythm and the level of block: sinus, AV node (narrow escape) or below the node (wide escape).
- Mobitz II and third-degree block with a wide QRS are the rhythms most likely to fail suddenly.
Causes to treat
- Hypoxia, inferior infarction, hyperkalemia, hypothermia, raised intracranial pressure.
- Drugs: beta-blockers, calcium-channel blockers, digoxin, clonidine and others.
Energies, doses and targets
| What | As the guideline states it | Source |
|---|---|---|
| Atropine IV | First dose 1 mg bolus; repeat every 3–5 minutes; maximum 3 mg | AHA 2020 adult algorithm |
| Dopamine IV infusion | 5–20 mcg/kg per minute; titrate to patient response; taper slowly | AHA 2020 adult algorithm |
| Epinephrine IV infusion | 2–10 mcg per minute; titrate to patient response | AHA 2020 adult algorithm |
Mechanisms, cautions and pediatric doses: the drugs. Practise it: megacode cases.
Guidelines and sources
Reflects the AHA 2020 adult algorithms with the 2023 focused update, updated for the 2025 AHA Guidelines for CPR and ECC where the change could be confirmed; acute coronary syndromes follow the 2025 ACC/AHA guideline and stroke the 2026 AHA/ASA guideline.
Algorithms and doses follow the AHA 2020 Guidelines for CPR and ECC, adult algorithms (Part 3: Adult Basic and Advanced Life Support, Circulation 2020;142(suppl 2):S366–S468), checked for changes in:
- 2023 AHA Focused Update on Adult Advanced Cardiovascular Life Support (Circulation 2024;149:e254–e273)
- 2025 AHA Guidelines for CPR and ECC, Part 9: Adult Advanced Life Support
Changes in the 2025 guidelines reflected here:
- Synchronized cardioversion of atrial fibrillation: an initial energy of at least 200 J with a biphasic defibrillator is now recommended, rather than a lower first shock.
- The tachycardia algorithm refers to the device's recommended energy level rather than listing energies for each rhythm.
- Intravenous access is preferred to intraosseous access as the first attempt in cardiac arrest.
- Double sequential defibrillation and vector-change defibrillation for refractory VF remain of uncertain benefit.
- Sotalol is no longer listed in the tachycardia algorithm; procainamide and amiodarone remain.
- Routine calcium and sodium bicarbonate are not recommended in cardiac arrest; both are kept for specific causes.
- After ROSC: titrate oxygen to an SpO₂ of 90–98%, keep the MAP at 65 mm Hg or more, and use deliberate temperature control (32–37.5 °C) for patients not following commands.
- Polymorphic VT is treated as unstable and defibrillated.
Sources:
- Panchal AR, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 suppl 2):S366–S468.
- Perman SM, et al. 2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support. Circulation. 2024;149:e254–e273.
- Lavonas EJ, et al. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning. Circulation. 2023;148:e149–e184.
- Part 7: Adult Basic Life Support. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
- Part 9: Adult Advanced Life Support. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2):S538–S577.
- Part 10: Adult and Pediatric Special Circumstances of Resuscitation. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
- Part 11: Post–Cardiac Arrest Care. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
- Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025;151(13):e771–e862.
- Prabhakaran S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke (AHA/ASA). Stroke. 2026. doi:10.1161/STR.0000000000000513.
The full 2025 guideline text could not be opened when this page was drafted; the 2025 changes listed were confirmed from summaries of AHA's published 2025 algorithms and highlights. Drug doses are the 2020 algorithm doses, which those 2025 algorithms keep. All text and pictures here are original teaching material, not reproductions of AHA algorithms. Education only, not a treatment protocol.